Barely Significant
← all excerpts

Tofacitinib Treatment Suppresses CD4+ T-Cell Activation and Th1 Response, Contributing to Protection against Staphylococcal Toxic Shock.

Int J Mol Sci · 2024 · PMC11242597 · PMID 39000566

2
hedged sentences
closest p
boldest claim

The sentences

showed a trendno p-value reported
Il-12 expression was significantly higher in toxin-challenged controls compared to mice with tofacitinib treatment, while Ifn-γ showed a trend towards downregulation by tofacitinib.

also in 53,322 other papers

a strong trendno p-value reported
Similarly to what was seen in previously examined mRNA expression, the level of IL-12 was significantly lower in tofacitinib-treated animals compared to toxin-challenged controls ( Figure 4 a), while IFN-γ showed a strong trend in the same direction ( Figure 4 b).

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.